Chronos Archive seal
The Human Record

Fannie Lou Hamer

Case HR-ML031-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
October 6, 1917 – March 14, 1977
Synthetic DOB
1917-10-06
Index visit
1967-03-09 at age 49
Synthetic MRN
HR-ML031-SYN-TD

Teaching objective: Hypertension, type 2 diabetes and kidney disease in a 49-year-old community organizer in the rural Mississippi Delta, managed at a community health center with trauma-informed care. The teaching contrast is her documented sterilization without consent: here every examination, test and procedure is explained beforehand, done only with her documented consent, with a chaperone of her choosing, and stopped or declined at her word without loss of care. The episode covers confirming hypertension with home readings under the 1966 AHA/ACC guideline, diagnosing and treating diabetes under the ADA Standards of Care 1967, kidney function and urine albumin with KDIGO, an ACE inhibitor and an SGLT2 inhibitor, a statin, retinal photographs, foot care, medication choices for cost and adherence, a community health worker on the team, a social needs screen with real resources for food, transportation and utility costs, shared decisions, and preventive care.

Historical timeline

DateEventClaims
October 6, 1917Born in Montgomery County, Mississippi.CLM-0001
1961Operation for a uterine tumor, with a hysterectomy done without her knowledge or consent.CLM-0003
August 31, 1962Tried to register to vote; evicted from the plantation the same night.CLM-0002, CLM-0004
June 9, 1963Arrested and beaten in the Winona jail; lifelong injuries to her eyes, legs and kidneys.CLM-0005, CLM-0006
August 22, 1964Testimony before the Credentials Committee in Atlantic City.CLM-0007
early 1977Final hospital admission in Mound Bayou for complications of heart disease, diabetes and breast cancer.CLM-0008
March 14, 1977Died in Mound Bayou at 59.CLM-0009

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Fannie Lou Hamer was born on October 6, 1917, in Montgomery County, Mississippi, the twentieth child of Lou Ella and James Lee Townsend, sharecroppers. She joined her family in the cotton fields at six and left school after the sixth grade, at 12, to work on the cotton plantations of the Delta. confirmed Fannie Lou Hamer (biography) supports
Fannie Lou Hamer supports
Fannie Lou Hamer (Freedom Summer, American Experience) supports
HISTMED Master Roster v3 context
D She worked for eighteen years as a sharecropper and timekeeper on a Delta plantation, made timekeeper because she could read and write. In 1964 she gave her home as Ruleville, in Sunflower County, Mississippi.
Anchors her literacy, her rural Delta home and her work history in the modern social history.
confirmed Fannie Lou Hamer supports
Fannie Lou Hamer: Testimony Before the Credentials Committee, Democratic National Convention, August 22, 1964 (Say It Plain) supports
D In 1961, hospitalized for abdominal pain, she was found to have a uterine tumor; during the operation to remove it, a white surgeon performed a hysterectomy without her knowledge or informed consent. She later called this a "Mississippi appendectomy," a name for the sterilizations done without consent to Black women in the South.
The anchor for the teaching contrast: in the modern episode every examination, test and procedure is explained in advance and done only with her documented consent, and her right to refuse is respected. Her mistrust of medical care was earned.
confirmed Fannie Lou Hamer (biography) supports
Fannie Lou Hamer (Freedom Summer, American Experience) supports
Bunch M. Why civil rights icon Fannie Lou Hamer was 'sick and tired of being sick and tired' supports
Ladd D. Editor's Note: As You Vote, Recall the Blackjacks Hitting Mrs. Hamer's Back supports
D On August 31, 1962, she tried to register to vote in Indianola; when she refused to withdraw her application, the plantation owner ordered her off his land and she had to leave that same night. confirmed Fannie Lou Hamer supports
Fannie Lou Hamer: Testimony Before the Credentials Committee, Democratic National Convention, August 22, 1964 (Say It Plain) supports
D On June 9, 1963, returning from a voter-registration workshop, she was arrested with other activists in Winona, Mississippi, and in the jail two Black prisoners were ordered by officers to beat her with a blackjack, as she testified the next year.
Anchors the history of injury and the trauma-informed approach in the modern episode.
confirmed Fannie Lou Hamer: Testimony Before the Credentials Committee, Democratic National Convention, August 22, 1964 (Say It Plain) supports
Remembering 1963: Fannie Lou Hamer Arrested and Beaten in Winona, Mississippi supports
Beatings in Winona Jail supports
D The beating left her with lifelong injuries to her eyes, legs and kidneys: permanent kidney damage, and a blood clot in her left eye with loss of vision in one eye.
The anchor for the modern kidney history and the reduced vision in her left eye. The modern kidney findings are synthetic.
confirmed Fannie Lou Hamer (Freedom Summer, American Experience) supports
Bunch M. Why civil rights icon Fannie Lou Hamer was 'sick and tired of being sick and tired' supports
Remembering 1963: Fannie Lou Hamer Arrested and Beaten in Winona, Mississippi supports
Barnes J. Winona marks where civil rights leader Fannie Lou Hamer was beaten inside city jail after nearly 60 years supports
Turner T. Fannie Lou Hamer supports
D On August 22, 1964, she testified before the Credentials Committee of the Democratic National Convention in Atlantic City about her eviction and the Winona beating. confirmed Fannie Lou Hamer: Testimony Before the Credentials Committee, Democratic National Convention, August 22, 1964 (Say It Plain) supports
Fannie Lou Hamer (biography) supports
D In her late fifties she found a lump in her left breast and did not seek care for it at first. Appeals were made to help with her mounting medical bills. In early 1977 she was admitted for the last time to the hospital in Mound Bayou, where she was treated for complications of heart disease, diabetes and breast cancer.
History after the modern episode. Anchors the later diabetes and the cost barriers in the modern record; the breast cancer appears only as history and in screening.
confirmed Loss of an Icon (Fannie Lou Hamer Resource Center, drawing on Brooks MP, Fannie Lou Hamer: America's Freedom Fighting Woman) supports
D She died on March 14, 1977, in Mound Bayou, Mississippi, at 59. Accounts of the cause differ: complications of hypertension and breast cancer, complications of heart disease and cancer, or breast cancer.
History only, a decade after the modern episode. Anchors the later hypertension.
confirmed Turner T. Fannie Lou Hamer supports
Fannie Lou Hamer (Freedom Summer, American Experience) supports
Fannie Lou Hamer (biography) supports
Loss of an Icon (Fannie Lou Hamer Resource Center, drawing on Brooks MP, Fannie Lou Hamer: America's Freedom Fighting Woman) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later life active confirmed both_with_link CLM-0008
S Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirm resolved confirmed active CLM-0009
S Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigated resolved confirmed active CLM-0005, CLM-0006
S Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later life active confirmed both_with_link CLM-0009
S Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contribute active confirmed active CLM-0005, CLM-0006
S Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention) active confirmed active CLM-0008
S Food insecurity: food runs out before the end of most months active confirmed active
S Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrange active confirmed active CLM-0002
S Hyperlipidemia: LDL 146 mg/dL active confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1967-03-09 Hemoglobin A1c/Hemoglobin.total in Blood 8.6% (high)
Reference Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for her
http://loinc.org · 4548-4
S 1967-03-09 Glucose [Mass/volume] in Serum or Plasma 238 mg/dL (high)
Reference Random sample; 200 mg/dL or higher with symptoms is diagnostic of diabetes
http://loinc.org · 2345-7
S 1967-03-09 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1967-03-09 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1967-03-09 Creatinine [Mass/volume] in Serum or Plasma 0.96 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1967-03-09 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M 73 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1967-03-09 Albumin/Creatinine [Mass Ratio] in Urine 88 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1967-03-09 Cholesterol [Mass/volume] in Serum or Plasma 228 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1967-03-09 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 146 mg/dL (high)
Reference Goal below 70 mg/dL with diabetes and kidney disease
http://loinc.org · 13457-7
S 1967-03-09 Cholesterol in HDL [Mass/volume] in Serum or Plasma 44 mg/dL (low)
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 1967-03-09 Triglyceride [Mass/volume] in Serum or Plasma 190 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1967-03-09 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1967-03-09 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 1967-03-09 Hemoglobin [Mass/volume] in Blood 12.6 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1967-03-09 Platelets [#/volume] in Blood by Automated count 268 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1967-03-09 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 1967-03-09 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 1967-03-09 Accountable health communities (AHC) health-related social needs screening (HRSN) tool 3 http://loinc.org · 96777-8
S 1967-03-23 Albumin/Creatinine [Mass Ratio] in Urine 96 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1967-05-04 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1967-05-04 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1967-05-04 Creatinine [Mass/volume] in Serum or Plasma 1.04 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1967-05-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M 66 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1967-05-04 Cholesterol [Mass/volume] in Serum or Plasma 154 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1967-05-04 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 80 mg/dL
Reference Goal below 70 mg/dL with diabetes and kidney disease
http://loinc.org · 13457-7
S 1967-05-04 Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 mg/dL (low)
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 1967-05-04 Triglyceride [Mass/volume] in Serum or Plasma 142 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1967-05-04 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1967-07-13 Hemoglobin A1c/Hemoglobin.total in Blood 7.3% (high)
Reference Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for her
http://loinc.org · 4548-4
S 1967-07-13 Albumin/Creatinine [Mass Ratio] in Urine 52 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1967-07-13 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1967-07-13 Creatinine [Mass/volume] in Serum or Plasma 1.02 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1967-07-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M 67 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1967-07-13 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 1967-07-13 Accountable health communities (AHC) health-related social needs screening (HRSN) tool 1 http://loinc.org · 96777-8
S 1967-10-19 Hemoglobin A1c/Hemoglobin.total in Blood 6.9% (high)
Reference Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for her
http://loinc.org · 4548-4
S 1967-10-19 Albumin/Creatinine [Mass Ratio] in Urine 41 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1967-10-19 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1967-10-19 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1967-10-19 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M 69 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1967-10-19 Accountable health communities (AHC) health-related social needs screening (HRSN) tool 1 http://loinc.org · 96777-8
S 1967-09-14 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7

Synthetic vital signs

DateMeasureResultLOINCGrade
1967-03-09Body height163 cm8302-2S
1967-03-09Body weight93 kg29463-7S
1967-03-09Body mass index (BMI) [Ratio]35 kg/m239156-5S
1967-03-09Systolic blood pressure164 mm[Hg]8480-6S
1967-03-09Diastolic blood pressure98 mm[Hg]8462-4S
1967-03-09Heart rate84 /min8867-4S
1967-03-09Respiratory rate16 /min9279-1S
1967-03-09Body temperature36.8 Cel8310-5S
1967-03-09Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1967-03-23Body height163 cm8302-2S
1967-03-23Body weight92.6 kg29463-7S
1967-03-23Body mass index (BMI) [Ratio]34.9 kg/m239156-5S
1967-03-23Systolic blood pressure156 mm[Hg]8480-6S
1967-03-23Diastolic blood pressure96 mm[Hg]8462-4S
1967-03-23Heart rate82 /min8867-4S
1967-03-23Respiratory rate16 /min9279-1S
1967-03-23Body temperature36.7 Cel8310-5S
1967-03-23Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1967-05-04Body height163 cm8302-2S
1967-05-04Body weight91.8 kg29463-7S
1967-05-04Body mass index (BMI) [Ratio]34.6 kg/m239156-5S
1967-05-04Systolic blood pressure136 mm[Hg]8480-6S
1967-05-04Diastolic blood pressure84 mm[Hg]8462-4S
1967-05-04Heart rate78 /min8867-4S
1967-05-04Respiratory rate16 /min9279-1S
1967-05-04Body temperature36.6 Cel8310-5S
1967-05-04Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1967-07-13Body height163 cm8302-2S
1967-07-13Body weight90.9 kg29463-7S
1967-07-13Body mass index (BMI) [Ratio]34.2 kg/m239156-5S
1967-07-13Systolic blood pressure128 mm[Hg]8480-6S
1967-07-13Diastolic blood pressure78 mm[Hg]8462-4S
1967-07-13Heart rate76 /min8867-4S
1967-07-13Respiratory rate16 /min9279-1S
1967-07-13Body temperature36.9 Cel8310-5S
1967-07-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1967-10-19Body height163 cm8302-2S
1967-10-19Body weight90 kg29463-7S
1967-10-19Body mass index (BMI) [Ratio]33.9 kg/m239156-5S
1967-10-19Systolic blood pressure124 mm[Hg]8480-6S
1967-10-19Diastolic blood pressure76 mm[Hg]8462-4S
1967-10-19Heart rate74 /min8867-4S
1967-10-19Respiratory rate16 /min9279-1S
1967-10-19Body temperature36.7 Cel8310-5S
1967-10-19Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1967-09-14Body height163 cm8302-2S
1967-09-14Body weight90.4 kg29463-7S
1967-09-14Body mass index (BMI) [Ratio]34 kg/m239156-5S
1967-09-14Systolic blood pressure126 mm[Hg]8480-6S
1967-09-14Diastolic blood pressure78 mm[Hg]8462-4S
1967-09-14Heart rate74 /min8867-4S
1967-09-14Respiratory rate16 /min9279-1S
1967-09-14Body temperature36.7 Cel8310-5S
1967-09-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Every examination, test and procedure explained first and done only with her documented agreement, with a chaperone of her choosing, at every visit1967-10-19completedConsent documented for every examination, blood draw, ultrasound, photograph, vaccine and screening test; she declined a breast and a pelvic examination, and that was respected
Blood pressure below 130/80 mmHg in the clinic and at home within six months1967-10-19completed124/76 in the clinic; home average 126/78
A1c below 7% within six to nine months, without low blood sugar1967-10-19completed6.9% at seven months; no low blood sugar
Urine albumin-to-creatinine ratio lower by at least 30% within six months1967-10-19completed88 to 96 mg/g at baseline; 41 mg/g at seven months
Food and utility needs met through benefits, and a dependable way to reach every visit and laboratory test1967-10-19activeSNAP and energy assistance in place; rides arranged for every visit after one missed laboratory check; transportation still uncertain on some days
LDL cholesterol below 70 mg/dL1967-10-19active146 to 80 mg/dL on atorvastatin; recheck with the yearly panel

Interventions

InterventionStatusGuideline
Consent-based, trauma-informed care at every visit: explain each examination, test and procedure beforehand (what it is, why, what it involves, the alternatives, including not doing it), ask her agreement and record it, offer a chaperone or companion of her choosing, let her stop at any time, never perform an unplanned procedure, and keep the plan in writing; written consent for any procedure beyond routine testscompletedGL-SAMHSA-TIP57-2014, GL-AMA-CONSENT, GL-ACOG-CONSENT-2021
Nephrology consultation by telehealth from the health center, with the community health worker present, for albumin in the urine and reduced kidney function in a woman with an old kidney injury, new diabetes and high blood pressure readingscompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026
Blood pressure: a validated home monitor with a large cuff, provided by the health center, with readings twice a day for seven days to confirm the diagnosis; less salt, using foods she can get; recheck in two weekscompletedGL-AHA-HTN-2025, GL-CMID-2026
Diabetes: metformin extended-release once daily, an A1c every three months until at goal, diabetes self-management education in a group class at the health center, and no medicine that can cause low blood sugarcompletedGL-ADA-2026, GL-CMID-2026
Kidneys: repeat the urine albumin test, a kidney ultrasound with the consultation, no ibuprofen or naproxen, and kidney function and potassium checks after any blood pressure or kidney medicine is startedcompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026
Cardiovascular risk: atorvastatin 40 mg with a lipid panel at four to twelve weeks, a baseline ECG, and TSH at diagnosiscompletedGL-ADA-2026, GL-AHA-HTN-2025, GL-CMID-2026
Eyes and feet: retinal photographs in the clinic, so that no separate trip is needed; a comprehensive foot examination yearly; daily foot checks at home, callus care at the health center and well-fitting shoescompletedGL-ADA-RETFOOT-2026
Social needs, with the community health worker: the AHC health-related social needs screen at intake and every few months; help applying for SNAP and the Low Income Home Energy Assistance Program; the health center's food pantry and produce program; 211 for other local help; rides arranged for every visit and laboratory test; the sliding-fee scale; 90-day medicine supplies at the discount pharmacy, and phone visits when travel is not possiblecompletedGL-AHC-HRSN, GL-ADA-POP-2026, GL-SNAP, GL-LIHEAP
Shared decisions and the team: Dr. Batiste-Hill, a nurse, the community health worker and the pharmacist review the plan with her; medicines chosen for cost, once-daily dosing and her preferences; she decides what she acceptscompletedGL-ADA-2026, GL-ACOG-CONSENT-2021
Mood and stress: PHQ-9 at intake and at four months, asked privately; counseling offered at her choicecompletedGL-USPSTF-DEP-2023, GL-CMID-2026
Vaccines: pneumococcal, hepatitis B and Tdap offered, explained and given only with her agreement; influenza and COVID-19 each autumncompletedGL-CDC-IMZ-2026
On the consultant's advice: amlodipine 5 mg with benazepril 20 mg in one daily capsule and dapagliflozin 10 mg daily with sick-day rules; potassium and creatinine one to two weeks after starting; urine albumin again at three to four months; blood pressure goal below 130/80; review of kidney treatment by telehealth if albumin stays raisedcompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026, GL-AHA-HTN-2025
Laboratory checks on the days she is already at the health center, with a ride arranged in advance for any extra check; home blood draw by the mobile phlebotomy service when no ride can be foundcompletedGL-ADA-POP-2026, GL-AHC-HRSN
Metformin extended-release increased to 1,500 mg with the evening meal, because the A1c was still above goalcompletedGL-ADA-2026, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Fannie Lou Hamer (biography) National Women's History Museum biography
SRC-0002 Fannie Lou Hamer SNCC Digital Gateway (SNCC Legacy Project and Duke University) biography
SRC-0003 Fannie Lou Hamer (Freedom Summer, American Experience) PBS biography
SRC-0004 Fannie Lou Hamer: Testimony Before the Credentials Committee, Democratic National Convention, August 22, 1964 (Say It Plain) American RadioWorks (American Public Media) primary
SRC-0005 Bunch M. Why civil rights icon Fannie Lou Hamer was 'sick and tired of being sick and tired' The Conversation other
SRC-0006 Remembering 1963: Fannie Lou Hamer Arrested and Beaten in Winona, Mississippi Equal Justice Initiative other
SRC-0007 Ladd D. Editor's Note: As You Vote, Recall the Blackjacks Hitting Mrs. Hamer's Back Mississippi Free Press other
SRC-0008 Beatings in Winona Jail SNCC Digital Gateway (SNCC Legacy Project and Duke University) biography
SRC-0009 Barnes J. Winona marks where civil rights leader Fannie Lou Hamer was beaten inside city jail after nearly 60 years WCBI-TV other
SRC-0010 Turner T. Fannie Lou Hamer UMKC Women's Center, University of Missouri-Kansas City other
SRC-0011 HISTMED Master Roster v3 The Human Record project other
SRC-0012 Loss of an Icon (Fannie Lou Hamer Resource Center, drawing on Brooks MP, Fannie Lou Hamer: America's Freedom Fighting Woman) Fannie Lou Hamer's America biography

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the confirmation of hypertension by home readings, the CKD G2 A2 classification with a scarred kidney, the single-pill amlodipine-benazepril, dapagliflozin and its sick-day rules, atorvastatin intensity, the eGFR without a race term, and the consent documentation at each visit.
provenance reviewnot_startedSources: the National Women's History Museum, the SNCC Digital Gateway, PBS, her own 1964 testimony (American RadioWorks), The Conversation, the Equal Justice Initiative, the Mississippi Free Press, WCBI, the UMKC Women's Center, and Fannie Lou Hamer's America. The Smithsonian and Library of Congress pages could not be fetched.
safe messaging reviewnot_startedThe sterilization and the beating are recorded as sensitive, plainly and without graphic detail. No mental health claim is made; mood screening is synthetic and below the threshold for a safety assessment. Her mistrust is presented as earned, and her refusals are respected, not labeled.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.